| Symbol | XCRT |
|---|---|
| Name | XCELERATE INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 29662 United States SC 110 Renaissance Circle |
| Telephone | +1 864-228-2222 |
| Fax | — |
| — | |
| Website | http://www.xcelerate.global |
| Incorporation | US |
| Incorporated On | 1996 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Bush & Associates CPA; |
| Audit Status | UNAUDITED |
| Reporting Status | Alternative Reporting Standard |
| CIK | 0001138586 |
| Description | Xcelerate has assembled an internationally recognized team of translational clinicians, engineers and business leaders to identify, acquire, and develop engineering advancements, intellectual property and operating business in, or with applications in medical technology and clinical care. Xcelerate acquires innovation at the engineering / patent level, marries it with appropriate early-stage operational med tech companies and applies it in a controlled clinical care setting which fosters engineering/clinical/business advancements under one umbrella. Additional info from OTC: |
New Form RW - Xcelerate, Inc. Filed: 2025-05-29 AccNo: 0001683168-25-004070 Size: 15 KB
Read moreNew Form 1-U - Xcelerate, Inc. Filed: 2025-05-06 AccNo: 0001683168-25-003184 Size: 13 KB
Read moreXcelerate, Inc. Announces the Launch of the Ceramedx Tik Tok Skincare Campaign
Read moreNew Form 1-SA - Xcelerate, Inc. Filed: 2024-09-24 AccNo: 0001683168-24-006616 Size: 307 KB
Read moreXcelerate, Inc. Announces Commencement of the Nationalization Process for its PCT International Patent Applications
Read more